285 related articles for article (PubMed ID: 9600016)
41. Epigenetic dysregulation in thyroid neoplasia.
Kondo T; Asa SL; Ezzat S
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
[TBL] [Abstract][Full Text] [Related]
42. Genome-wide combination profiling of copy number and methylation offers an approach for deciphering misregulation and development in cancer cells.
Park JJ; Kang JK; Hong S; Ryu ES; Kim JI; Lee JH; Seo JS
Gene; 2008 Jan; 407(1-2):139-47. PubMed ID: 17997235
[TBL] [Abstract][Full Text] [Related]
43. Neuro-oncogenesis. A review.
Dănăilă L
Rom J Neurol Psychiatry; 1992; 30(4):287-300. PubMed ID: 1299306
[No Abstract] [Full Text] [Related]
44. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
45. NF-kappaB: tumor promoter or suppressor?
Perkins ND
Trends Cell Biol; 2004 Feb; 14(2):64-9. PubMed ID: 15102437
[TBL] [Abstract][Full Text] [Related]
46. [Significance of oncogenes in development and prognosis of differentiated thyroid gland carcinomas].
Goretzki PE; Schulte KM
Internist (Berl); 1998 Jun; 39(6):584-7. PubMed ID: 9677513
[No Abstract] [Full Text] [Related]
47. [Analysis of oncogenes and tumor suppressor genes].
Sekiya T
Tanpakushitsu Kakusan Koso; 1993 Feb; 38(3):314-20. PubMed ID: 8488265
[No Abstract] [Full Text] [Related]
48. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment.
Harris CC
Prev Med; 1996; 25(1):10-2. PubMed ID: 8778751
[No Abstract] [Full Text] [Related]
49. MicroRNAs in human cancer: from research to therapy.
Negrini M; Ferracin M; Sabbioni S; Croce CM
J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
[TBL] [Abstract][Full Text] [Related]
50. Targeting lung cancer genes: a novel approach to cancer prevention and therapy.
Roth JA
Semin Thorac Cardiovasc Surg; 1993 Jul; 5(3):178-83. PubMed ID: 8353144
[No Abstract] [Full Text] [Related]
51. [Oncogenes and tumor suppressor genes: general features].
Piccinin S; Vukosavljevic T
Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):17-20. PubMed ID: 9036735
[No Abstract] [Full Text] [Related]
52. [Glucocorticoid regulated gene in cells of the immune system. Mechanisms of immunomodulation].
Fiegl M
Wien Klin Wochenschr; 1996; 108(2):48-50. PubMed ID: 8835433
[No Abstract] [Full Text] [Related]
53. Oncogenes and tumor suppressor genes--two different looks of the same gene?
Călin G
Roum Arch Microbiol Immunol; 1992; 51(4):271-3. PubMed ID: 1304831
[No Abstract] [Full Text] [Related]
54. A bumper crop of cancer genes.
DePinho RA; Jacks T
Nat Genet; 1999 Nov; 23(3):253-4. PubMed ID: 10545932
[No Abstract] [Full Text] [Related]
55. [Oncogenes--motors of the cancer cell].
Schraml P
Praxis (Bern 1994); 2004 May; 93(22):957-9. PubMed ID: 15216926
[No Abstract] [Full Text] [Related]
56. [Cell cycle, tumor suppressor genes and lung cancers].
Bréchot JM
Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
[TBL] [Abstract][Full Text] [Related]
57. [Oncogene and tumor suppressor gene].
Watanabe N
Rinsho Byori; 2002 Nov; Suppl 123():131-6. PubMed ID: 12652800
[TBL] [Abstract][Full Text] [Related]
58. OncomiRs: the discovery and progress of microRNAs in cancers.
Cho WC
Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic biomarkers for human cancer: the time is now.
Mulero-Navarro S; Esteller M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
[TBL] [Abstract][Full Text] [Related]
60. [Molecular basis of cancer].
Meza-Junco J; Montaño-Loza A; Aguayo-González A
Rev Invest Clin; 2006; 58(1):56-70. PubMed ID: 16789600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
